Search All UT System Experts

Efficacy and safety of long-term treatment with the dual 5α-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia

Frans Debruyne, Jack Barkin, Peter Van Erps, Mario Reis, Teuvo L J Tammela, Claus Roehrborn

Research output: Contribution to journal › Article › peer-review

208 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of long-term treatment with the dual 5α-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences